The Effect of Endochin on Experimental Toxoplasmosis 1,2
- 1 January 1951
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. s1-31 (1), 12-17
- https://doi.org/10.4269/ajtmh.1951.s1-31.12
Abstract
Summary A new drug, Endochin, is reported which possesses activity against experimental toxoplasmosis. Of the sulfa derivatives tested, sulfadiazine and Promin proved to have comparable or greater effect on the infection than Endochin. Other drugs selected for their activity against the exoerythrocytic stages of malaria and which proved to be ineffective in toxoplasmosis included a sulfanilanilide (SN 187), a metanilamide (SN 11,437), a naphthoquinone (SN 8557), an 8-amino-quinoline (SN 13,276), a biguanide (SN 12,837), and an acridone (DR 15,575). Treatment combining sulfadiazine and Endochin was no more efficacious than treatment with either drug by itself.Keywords
This publication has 3 references indexed in Scilit:
- The Effects of Oral Administration of Aureomycin, Sulfathiazole, Sulfamerazine and 4,4′-Diamino Diphenyl Sulfone on Toxoplasmosis in Mice 1The American Journal of Tropical Medicine and Hygiene, 1949
- Symposium on Exoerythrocytic Forms of Malarial Parasites. III. The Chemotherapy of Malaria in Relation to Our Knowledge of Exoerythrocytic FormsJournal of Parasitology, 1948
- Chronic ToxoplasmosisThe Journal of Infectious Diseases, 1943